Befejeződött1. fázis
Single-dose Study of BMS-986326 at Two Dose Levels in Participants with Atopic Dermatitis
Key facts
- Where
- Berlin, Bremen, Chemnitz, Dessau-Rosslau, Heidelberg és Lübeck, NémetországSee the 6 sites
- Phase
- 1. fázis
Where in Németország
- Charite Research Organisation GmbHBerlin, NémetországNo longer taking part
- Gesundheit Nord gGmbH Klinikverbund BremenBremen, NémetországNo longer taking part
- Deutsches Rotes Kreuz Gemeinnuetzige Krankenhaus GmbH SachsenChemnitz, NémetországNo longer taking part
- Staedtisches Klinikum DessauDessau-Rosslau, NémetországNo longer taking part
- Universitaetsklinikum Heidelberg AöRHeidelberg, NémetországNo longer taking part
- University Medical Centre Schleswig-HolsteinLübeck, NémetországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Bristol-Myers Squibb Services Unlimited Company
- Trial code
- EU 2022-502997-18-00
- Record updated
- 2025. november 5.